Loading clinical trials...
Loading clinical trials...
Phase 4 Study of Recombinant GH on Intima-Media Thickness at Common Carotids and on Cardiovascular Risk Factors in Hypopituitary Patients
Conditions
Interventions
Recombinant Growth Hormone, Genotropin (Pfizer)
Locations
1
Italy
Department of Molecular and Clinical Endocirnology and Oncology University Federico II of Naples
Naples, Italy
Start Date
January 1, 1996
Completion Date
December 1, 2006
Last Updated
October 16, 2007
NCT00001595
NCT07333521
NCT00227253
NCT04463316
NCT06109935
NCT05230550
Lead Sponsor
Federico II University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions